SCHEMBL6557530

SCHEMBL6557530

O=C([N]C1CNCC1=O)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
RAB9A P51151 2/20 0.38
CYP2C19 P33261 2/20 0.38
NPC1 O15118 1/20 0.38
CYP1A2 P05177 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CHRNB2 P17787 2/20 0.37
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37
CHRNA7 P36544 2/20 0.37
CHRNA4 P43681 2/20 0.37
MCL1 Q07820 1/20 0.35
CES2 O00748 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8396819 0.71 TDP1 (0.44) HTTTDP1CYP2C19SMN1; SMN2CHRNA7
SCHEMBL6217856 0.70 KMT2A (0.43) HTTTDP1CHRNB2CHRNB4CHRNA3
SCHEMBL3033731 0.68 MCL1 (0.44) HTTTDP1RAB9ACYP2C19NPC1
SCHEMBL8396484 0.68 TDP1 (0.41) HTTTDP1RAB9ACYP2C19NPC1
SCHEMBL6557535 0.68 DDB1 (0.52) HTTRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL8396555 0.67 MCL1 (0.43) HTTTDP1RAB9ACYP2C19NPC1
SCHEMBL5168305 0.67 MCL1 (0.43) HTTTDP1RAB9ACYP2C19NPC1
SCHEMBL8394538 0.67 MCL1 (0.43) HTTTDP1RAB9ACYP2C19NPC1
SCHEMBL810830 0.62 CES1 (0.50) TDP1CYP2C19SMN1; SMN2CES2ALDH1A1
SCHEMBL543877 0.61 CES1 (0.55) TDP1CYP2C19SMN1; SMN2CES2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP disclosed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO disclosed